Two Sigma Investments LP Sells 3,255 Shares of Chemed Co. (NYSE:CHE)

Two Sigma Investments LP lessened its stake in Chemed Co. (NYSE:CHE - Free Report) by 38.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,303 shares of the company's stock after selling 3,255 shares during the quarter. Two Sigma Investments LP's holdings in Chemed were worth $2,810,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Tidal Investments LLC raised its stake in Chemed by 1,315.1% in the fourth quarter. Tidal Investments LLC now owns 24,085 shares of the company's stock valued at $12,760,000 after purchasing an additional 22,383 shares in the last quarter. Second Line Capital LLC raised its stake in Chemed by 16.4% in the fourth quarter. Second Line Capital LLC now owns 5,353 shares of the company's stock valued at $2,836,000 after purchasing an additional 756 shares in the last quarter. Snowden Capital Advisors LLC raised its stake in Chemed by 17.4% in the fourth quarter. Snowden Capital Advisors LLC now owns 1,105 shares of the company's stock valued at $585,000 after purchasing an additional 164 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in Chemed in the fourth quarter valued at about $54,587,000. Finally, Quantinno Capital Management LP raised its stake in Chemed by 5.4% in the fourth quarter. Quantinno Capital Management LP now owns 1,673 shares of the company's stock valued at $886,000 after purchasing an additional 86 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the company's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the completion of the transaction, the chief executive officer now owns 101,197 shares of the company's stock, valued at $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last 90 days, insiders sold 7,500 shares of company stock valued at $4,401,120. 3.29% of the stock is currently owned by corporate insiders.

Chemed Trading Down 1.3%

NYSE CHE traded down $7.43 during trading on Wednesday, hitting $560.96. 90,530 shares of the company's stock were exchanged, compared to its average volume of 103,378. The company has a market cap of $8.21 billion, a PE ratio of 28.35, a P/E/G ratio of 2.15 and a beta of 0.59. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.61. The stock's 50 day moving average price is $578.07 and its two-hundred day moving average price is $565.95.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.20 earnings per share. Analysts forecast that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.36%. The ex-dividend date is Thursday, May 29th. Chemed's payout ratio is 9.74%.

Analyst Ratings Changes

CHE has been the subject of a number of analyst reports. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada boosted their target price on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.